A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: Results from a phase II study

  1. Antolín, S.
  2. Mel, R.
  3. Ramos, M.
  4. García-Palomo, A.
  5. Almanza, C.
  6. Paz, L.
  7. Calvo, L.
  8. Álvarez, E.
  9. González, A.
  10. García-Mata, J.
Journal:
Clinical and Translational Oncology

ISSN: 1699-3055,  1699-048X

Year of publication: 2011

Volume: 13

Issue: 9

Pages: 686-691

Type: Article

DOI: 10.1007/S12094-011-0715-9 GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus